19. Which of the following therapeutic strategies with glycoprotein IIb/IIIa inhibitors is correct during a ST elevation myocardial infarction?

A. Abciximab started prior to percutaneous coronary intervention

B. Tirofiban started prior to percutaneous coronary intervention

C. Eptifibatide started at the time of percutaneous coronary intervention

D. Abciximab started at the time of percutaneous coronary intervention

E. Both A and B are correct

F. Both C and D are correct

PROCEED TO ANSWER